CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Go back to CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.43 --0 (-0%)
Previous Close $8.43    52 Week High $4.54 
Open $8.43    52 Week Low $1.15 
Day High $8.43    P/E N/A 
Day Low $8.43    EPS $-0.55 
Volume 256